Thompson, E., Landi, D., Lipp, E., Balajonda, B., Herndon, J., Buckley, E., … Sampson, J. (2020). CTIM-21. PEPTIDE VACCINE DIRECTED TO CMV pp65 FOR TREATMENT OF RECURRENT MALIGNANT GLIOMA AND MEDULLOBLASTOMA IN CHILDREN AND YOUNG ADULTS: PRELIMINARY RESULTS OF A PHASE I TRIAL. In Neuro-Oncology (Vol. 22, pp. ii37–ii37). Oxford University Press (OUP). https://doi.org/10.1093/neuonc/noaa215.155

Thompson, Eric, Daniel Landi, Eric Lipp, Bea Balajonda, James Herndon, Evan Buckley, Charlene Flahiff, et al. “CTIM-21. PEPTIDE VACCINE DIRECTED TO CMV pp65 FOR TREATMENT OF RECURRENT MALIGNANT GLIOMA AND MEDULLOBLASTOMA IN CHILDREN AND YOUNG ADULTS: PRELIMINARY RESULTS OF A PHASE I TRIAL.” In Neuro-Oncology, 22:ii37–ii37. Oxford University Press (OUP), 2020. https://doi.org/10.1093/neuonc/noaa215.155.

Thompson E, Landi D, Lipp E, Balajonda B, Herndon J, Buckley E, et al. CTIM-21. PEPTIDE VACCINE DIRECTED TO CMV pp65 FOR TREATMENT OF RECURRENT MALIGNANT GLIOMA AND MEDULLOBLASTOMA IN CHILDREN AND YOUNG ADULTS: PRELIMINARY RESULTS OF A PHASE I TRIAL. In: Neuro-Oncology. Oxford University Press (OUP); 2020. p. ii37–ii37.

Thompson, Eric, et al. “CTIM-21. PEPTIDE VACCINE DIRECTED TO CMV pp65 FOR TREATMENT OF RECURRENT MALIGNANT GLIOMA AND MEDULLOBLASTOMA IN CHILDREN AND YOUNG ADULTS: PRELIMINARY RESULTS OF A PHASE I TRIAL.” Neuro-Oncology, vol. 22, no. Supplement_2, Oxford University Press (OUP), 2020, pp. ii37–ii37. Manual, doi:10.1093/neuonc/noaa215.155.

Thompson E, Landi D, Lipp E, Balajonda B, Herndon J, Buckley E, Flahiff C, Jaggers D, Schroeder K, Randazzo D, Desjardins A, Johnson M, Peters K, Khasraw M, Malinzak M, Mitchell D, Ashley D, Sampson J. CTIM-21. PEPTIDE VACCINE DIRECTED TO CMV pp65 FOR TREATMENT OF RECURRENT MALIGNANT GLIOMA AND MEDULLOBLASTOMA IN CHILDREN AND YOUNG ADULTS: PRELIMINARY RESULTS OF A PHASE I TRIAL. Neuro-Oncology. Oxford University Press (OUP); 2020. p. ii37–ii37.